Fosamax

A new study shows that bisphosphonate drugs like Fosamax may not lower the risk for colon cancer despite what previous studies have

Bisphosphonate drugs like Fosamax, Reclast, Actonel, and Boniva have been around since the 1990s, but researchers recently questioned how long they should be used.

On December 19^th 2011, Health Canada officials issued a warning against use of bisphosphonate drugs including Fosamax^®, Actonel^®, and other similar bone strengtheni

Drug manufacturer Merck & Co. recently settled an on-going lawsuit with its shareholders who claim the company concealed information about the cholesterol lowering drug Vytorin.

Three bellwether trials against drug manufacturer Merck & Co. are scheduled to take place this year.

According to a new study the risk for suffering a second femur fracture injury may be lowered when the use of bisphosph

Fosamax, Boniva, and Reclast medications are all included in a class of drugs referred to as “bisphosphonates,” which are designed to strengthen weaken bones.

Three bellwether trials are scheduled to take place in 2012 against Merck & Company, manufacturer of the popular bisphosphonate medication known as Fosamax. U.S.

On December 15, 2011, a Fosamax lawsuit was filed against drug makers Merck & Co.

Fosamax, a bisphosphonate drug, was first approved by the Food and Drug Administration (FDA) in 1995 to treat osteoporosis in women.